The role of radiography and MRI for eligibility assessment in DMOAD trials of knee OA.
The role of radiography and MRI for eligibility assessment in DMOAD trials of knee OA.
复制标题
DOI:
10.1038/s41584-018-0010-z
复制
发表时间:
2018-06
期刊:
影响因子:
--
通讯作者:
Guermazi A
中科院分区:
文献类型:
--
作者:
Roemer FW;Kwoh CK;Hayashi D;Felson DT;Guermazi A
Currently no disease-modifying drugs for osteoarthritis have been approved. There are several reasons for failure of clinical trials in the past, including the commonly applied definition of structural eligibility based on radiographic assessment. In the context of precision medicine it will be of increasing relevance to find the appropriate patient for a specific treatment approach. Phenotypical stratification by imaging at eligibility will be paramount in the future and cannot be achieved using radiography alone. Furthermore, joints at high risk for faster progression need to be identified, as these may allow a more efficient DMOAD trial design. In addition, joints at high risk for collapse need to be excluded at screening. MRI may be able to offer solutions in this context, and commonly perceived hurdles in the application of MRI at eligibility assessment are being addressed as a result of technological advances and simplified image assessment.
登录
查看更多内容
影响因子:
19.7
作者:
Crema, Michel D.;Roemer, Frank W.;Guermazi, Ali
通讯作者:
Guermazi, Ali
影响因子:
2.8
作者:
Alexandersen, P.;Karsdal, M. A.;Christiansen, C.
通讯作者:
Christiansen, C.
影响因子:
7
作者:
Hayashi, D.;Felson, D. T.;Niu, J.;Hunter, D. J.;Roemer, E. W.;Aliabadi, P.;Guermazi, A.
通讯作者:
Guermazi, A.
影响因子:
27.4
作者:
Baker K;Grainger A;Niu J;Clancy M;Guermazi A;Crema M;Hughes L;Buckwalter J;Wooley A;Nevitt M;Felson DT
通讯作者:
Felson DT
影响因子:
--
作者:
Hunter, DJ;Zhang, YQ;Felson, DT
通讯作者:
Felson, DT